# Annoroad Gene Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/annoroad-gene-technology

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.annoroad.com
- Total disclosed funding: $105M
- Latest round: Series C (Nov 2, 2017)
- Investors on record: 8

## About

Established in 2012 and based in Beijing, China, Annoroad Gene Technology operates as a provider of gene sequencing services and diagnostic products.

## Funding rounds

- Series C, Nov 2, 2017, $105M — SAIF Partners, SB China Venture Capital, GTJA Investment Group, Ping An Trust
- Series B, Apr 9, 2015 — NLVC, China Renaissance Capital Investment, Guotai Junan Securities
- Series A, Dec 19, 2013 — NLVC, Guotai Junan Securities
- Angel, Jun 22, 2012 — Zhengxuan Capital

## Investors

- Zhengxuan Capital (https://capitalatlas.ai/funds/zhengxuan-capital) — Angel
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A, Series B
- Guotai Junan Securities — Series A, Series B
- China Renaissance Capital Investment (https://capitalatlas.ai/funds/china-renaissance-capital-investment) — Series B
- SAIF Partners (https://capitalatlas.ai/funds/saif-partners) — Series C
- SB China Venture Capital (https://capitalatlas.ai/funds/sb-china-venture-capital) — Series C
- GTJA Investment Group (https://capitalatlas.ai/funds/gtja-investment-group) — Series C
- Ping An Trust — Series C